SION (Sionna Therapeutics, Inc.) Stock Financials & Earnings

SIONSionna Therapeutics, Inc.

Mkt Cap$2B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$75M

EPS (TTM)-$1.70

Free Cash Flow (TTM)-$67M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Next: Q1 2026 · Mar 19

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 23	$0	$0	-$13M
Q1 24	$0	$0	-$13M
Q2 24	$0	-$166K	-$11M
Q3 24	$0	$0	-$28M
Q4 24	$0	$0	-$18M
Q1 25	$0	$0	-$20M
Q2 25	$0	-$147K	-$22M
Q3 25	$0	-$100K	-$24M
Q4 25	$0	$247K	-$24M

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q4 23	$10M	$3M	—
Q1 24	$10M	$3M	—
Q2 24	$8M	—	$3M
Q3 24	$25M	$4M	—
Q4 24	$14M	$4M	—
Q1 25	$14M	$6M	—
Q2 25	$15M	$7M	—
Q3 25	$16M	—	$8M
Q4 25	$15M	$17M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 23	$39M	$0	$39M
Q3 24	$36M	$102M	$137M
Q4 24	$38M	$110M	$148M
Q1 25	$83M	$187M	$270M
Q2 25	$41M	$222M	$263M
Q3 25	$51M	$197M	$248M
Q4 25	$58M	$177M	$236M

Shares Outstanding

Revenue Per Employee

Revenue / Employee